ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

New Trends in Pharmacological Treatments for Osteoarthritis

Cai, Xiaoyan; Yuan, Shiwen; Zeng, Yanting; Wang, Cuicui; Yu, Na*; Ding, Changhai*南方医科大学; 河北医科大学; 1
Frontiers in Pharmacology2021-4-15DOI: 10.3389/fphar.2021.645842
43被引15阅读
引用收藏
分享

摘要

Osteoarthritis (OA) is the leading cause of function loss and disability among the elderly, with significant burden on the individual and society. It is a severe disease for its high disability rates, morbidity, costs, and increased mortality. Multifactorial etiologies contribute to the occurrence and development of OA. The heterogeneous condition poses a challenge for the development of effective treatment for OA; however, emerging treatments are promising to bring benefits for OA management in the future. This narrative review will discuss recent developments of agents for the treatment of OA, including potential disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics for pain relief. This review will focus more on drugs that have been in clinical trials, as well as attractive drugs with potential applications in preclinical research. In the past few years, it has been realized that a complex interaction of multifactorial mechanisms is involved in the pathophysiology of OA. The authors believe there is no miracle therapeutic strategy fitting for all patients. OA phenotyping would be helpful for therapy selection. A variety of potential therapeutics targeting inflammation mechanisms, cellular senescence, cartilage metabolism, subchondral bone remodeling, and the peripheral nociceptive pathways are expected to reshape the landscape of OA treatment over the next few years. Precise randomized controlled trials (RCTs) are expected to identify the safety and efficacy of novel therapies targeting specific mechanisms in OA patients with specific phenotypes.

学科与关键词

关键词
osteoarthritisnovel therapeuticsDMOADstherapy selectionclinical prospect
相关
加载中…
  • Latest insights in disease-modifying osteoarthritis drugs development
    Li, Shengfa; Cao, Peihua; Chen, Tianyu; Ding, Changhai*Therapeutic Advances in Musculoskeletal Disease, 2023, 15: 1759720X231169839.被引 2
  • Shedding light on experimental intra-articular drugs for treating knee osteoarthritis
    Zhao, Yang; Ou, Qianhua; Cai, Yu; Ruan, Guangfeng*; Zhang, Yan*; Ding, Changhai*EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32(6): 509-524.被引 1
  • The global state of research in pain management of osteoarthritis (2000–2019)
    Taoyu, Chen; Jiaying, Zhu; Yu, Zhao; Haoqian, Li; Pengcui, Li; Jianjun, Fan; Xiaochun, WeiMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(2): e23944.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-04-15
卷期
第 12 卷
页码
645842
DOI
10.3389/fphar.2021.645842
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Science Foundation of Guangzhou First People's Hospital

作者

  • C

    Cai, Xiaoyan (第一作者)

    1

  • Y

    Yuan, Shiwen

    1

查看全部 6 位作者收起作者
  • Z

    Zeng, Yanting

    1

  • W

    Wang, Cuicui

    1

  • Y

    Yu, Na (通讯)

    1

  • D

    Ding, Changhai (通讯)

    inst med · southern med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417